Start-Up Previews, April 2015
This Month's Profile Group, Prostate Cancer Diagnostics, features profiles of 3DBiopsy, Blue Earth Diagnostics, Prostate Management Diagnostics, and UroSens. Plus these Start-Ups Across Health Care: Global Blood Therapeutics, MenoGenix, and Velano Vascular.
You may also be interested in...
Velano Vascular Inc. aims to spare hospitalized patients the pain of numerous needle blood draws. It is commercializing a single-use, disposable vascular-access device that resembles a syringe and interacts with an existing peripheral intravenous catheter that has already been inserted in the patient’s hand or arm.
3DBiopsy LLC thinks its technology could significantly improve a physician’s ability to diagnose and treat patients suspected of having prostate cancer. It has developed a complete biopsy system that utilizes the start-up’s proprietary software to transform ultrasound or MRI imaging into 3D models of the prostate and give physicians a more accurate guide.
The lack of accurate tools for diagnosing the severity of prostate cancer creates opportunities for start-ups with novel approaches. Profiles of 3D Biopsy, Blue Earth Diagnostics, UroSens, and Prostate Management Diagnostics.